First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 127.05 USD -0.85% Market Closed
Updated: May 13, 2024

Dexcom Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dexcom Inc
Stock-Based Compensation Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Dexcom Inc
NASDAQ:DXCM
Stock-Based Compensation
$154.6m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
19%
Becton Dickinson and Co
NYSE:BDX
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Stock-Based Compensation
$241m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Stock-Based Compensation
$218m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Stock-Based Compensation
$606.3m
CAGR 3-Years
14%
CAGR 5-Years
17%
CAGR 10-Years
13%

See Also

What is Dexcom Inc's Stock-Based Compensation?
Stock-Based Compensation
154.6m USD

Based on the financial report for Mar 31, 2024, Dexcom Inc's Stock-Based Compensation amounts to 154.6m USD.

What is Dexcom Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
19%

Over the last year, the Stock-Based Compensation growth was 17%. The average annual Stock-Based Compensation growth rates for Dexcom Inc have been 8% over the past three years , 9% over the past five years , and 19% over the past ten years .